Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Weger, M; Steinbrugger, I; Renner, W; Pöschl, EM; Brockmann, T; Rabensteiner, DF; El-Shabrawi, Y; Haas, A.
Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.
Curr Eye Res. 2013; 38(12):1278-1282
Doi: 10.3109/02713683.2013.820329
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Weger Martin
- Co-Autor*innen der Med Uni Graz
- El-Shabrawi Yosuf
- Haas Anton
- Malle Eva Maria Birgit
- Rabensteiner Dieter Franz
- Renner Wilfried
- Steinbrugger Iris
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Retinal vein occlusion (RVO) is a major vision-threatening disease. Vitamin K epoxide reductase recycles reduced vitamin K, which is essential for the gamma carboxylation of clotting factors II, VII, IX, X and proteins C and S. Recently, the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A (rs9923231) polymorphism has been reported as a novel risk factor for RVO in a Turkish population. The present study was set to confirm or to refute this association in a larger cohort of patients with RVO. The present case-control study comprised 285 patients with central RVO, 401 patients with branch RVO and 333 control subjects. Genotypes of the VKORC1 -1639G>A polymorphism were determined by 5' exonuclease assay (TaqMan). No significant differences in either genotype distributions or allele frequencies of the vitamin K epoxide reductase complex subunit 1 -1639G>A polymorphism were found between patients and control subjects (p > 0.05). In a logistic regression analysis neither branch nor central RVO was predicted by the vitamin K epoxide reductase complex subunit 1 -1639G>A genotypes, but by arterial hypertension, ever-smoking status and in case of central RVO additionally by diabetes mellitus. Our data suggest that the vitamin K epoxide reductase complex subunit 1 -1639G>A gene polymorphism is unlikely a major risk factor for patients with either central or branch RVO.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aged, 80 and over -
- Case-Control Studies -
- Female -
- Genetic Predisposition to Disease - epidemiology
- Genotype -
- Humans -
- Logistic Models -
- Male -
- Middle Aged -
- Polymorphism, Single Nucleotide -
- Retinal Vein Occlusion - epidemiology
- Risk Factors -
- Vitamin K - metabolism
- Vitamin K Epoxide Reductases - genetics
- Find related publications in this database (Keywords)
- Branch retinal vein occlusion
- central retinal vein occlusion
- genetics
- risk factors
- VKORC1